JPMorgan Financial Files 424B2 Prospectus for New Securities Offering

TL;DR

**JPMorgan Financial is prepping a new securities offering, watch for details.**

AI Summary

JPMorgan Chase Financial Co. LLC filed a 424B2 prospectus on March 24, 2026, under SEC Accession No. 0001918704-26-007937. This filing is a preliminary pricing supplement for a securities offering, indicating that JPMorgan Chase Financial Co. LLC, a subsidiary of JPMorgan Chase & Co., is preparing to issue new securities. This matters to investors because it signals potential capital-raising activities, which could impact the company's financial structure and future earnings, potentially diluting existing shareholder value or providing funds for growth.

Why It Matters

This filing indicates JPMorgan Chase Financial Co. LLC is preparing to issue new securities, which could affect the parent company's capital structure and future financial performance.

Risk Assessment

Risk Level: medium — The filing itself is procedural, but the underlying securities offering could introduce market risk or dilution for existing shareholders.

Analyst Insight

Investors should monitor subsequent filings (like a final pricing supplement) to understand the specific terms, size, and type of securities being offered, as this will determine the potential impact on JPMorgan Chase & Co. stock.

Key Numbers

• 424B2 — Form Type (Indicates a prospectus for a securities offering)
• 0001918704-26-007937 — SEC Accession No. (Unique identifier for this specific filing)
• 333-270004-01 — File No. (Registration statement under which the securities are being offered)

Key Players & Entities

• JPMorgan Chase Financial Co. LLC (company) — Filer of the 424B2 prospectus
• JPMorgan Chase & Co (company) — Parent company of the filer
• 0001665650 (person) — CIK of JPMorgan Chase Financial Co. LLC
• 0000019617 (person) — CIK of JPMorgan Chase & Co
• 2026-03-24 (date) — Filing Date

FAQ

Key Financial Figures

• $1,000 — ribed below. Minimum denominations of $1,000 and integral multiples thereof The no
• $7.25 — t will these selling commissions exceed $7.25 per $1,000 principal amount note. See "
• $974.30 — lue of the notes would be approximately $974.30 per $1,000 principal amount note. The e
• $900.00 — ng supplement and will not be less than $900.00 per $1,000 principal amount note. See "
• $9.0417 — gent Interest Payment equal to at least $9.0417 (equivalent to a Contingent Interest Ra
• $207.9583 — tal Contingent Interest Payments 23 $207.9583 22 $198.9167 21 $189.8750 20
• $198.9167 — terest Payments 23 $207.9583 22 $198.9167 21 $189.8750 20 $180.8333 19
• $189.8750 — 23 $207.9583 22 $198.9167 21 $189.8750 20 $180.8333 19 $171.7917 18
• $180.8333 — 22 $198.9167 21 $189.8750 20 $180.8333 19 $171.7917 18 $162.7500 17
• $171.7917 — 21 $189.8750 20 $180.8333 19 $171.7917 18 $162.7500 17 $153.7083 16
• $162.7500 — 20 $180.8333 19 $171.7917 18 $162.7500 17 $153.7083 16 $144.6667 15
• $153.7083 — 19 $171.7917 18 $162.7500 17 $153.7083 16 $144.6667 15 $135.6250 14
• $144.6667 — 18 $162.7500 17 $153.7083 16 $144.6667 15 $135.6250 14 $126.5833 13
• $135.6250 — 17 $153.7083 16 $144.6667 15 $135.6250 14 $126.5833 13 $117.5417 12
• $126.5833 — 16 $144.6667 15 $135.6250 14 $126.5833 13 $117.5417 12 $108.5000 11

Filing Documents

• form424b2.htm (424B2) — 223KB
• image_001.jpg (GRAPHIC) — 21KB
• image_002.jpg (GRAPHIC) — 5KB
• image_006.jpg (GRAPHIC) — 176KB
• image_007.jpg (GRAPHIC) — 154KB
• image_008.jpg (GRAPHIC) — 139KB
• image_009.jpg (GRAPHIC) — 6KB
• image_010.jpg (GRAPHIC) — 5KB
• image_011.jpg (GRAPHIC) — 7KB
• image_003.gif (GRAPHIC) — 5KB
• image_004.gif (GRAPHIC) — 2KB
• image_005.gif (GRAPHIC) — 2KB
• 0001918704-26-007937.txt ( ) — 944KB

From the Filing

PRICING SUPPLEMENT The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. March , 2026 Registration Statement Nos. 333-270004 and 333-270004-01; Rule 424(b)(2) JPMorgan Chase Financial Company LLC Structured Investments Callable Contingent Interest Notes Linked to the Least Performing of the Dow Jones Industrial Average , the Nasdaq-100 Technology Sector Index SM and the Russell 2000 Index due March 2, 2028 Fully and Unconditionally Guaranteed by JPMorgan Chase & Co. The notes are designed for investors who seek a Contingent Interest Payment with respect to each Review Date for which the closing level of each of the Dow Jones Industrial Average , the Nasdaq-100 Technology Sector Index SM and the Russell 2000 Index, which we refer to as the Indices, is greater than or equal to 70.00% of its Initial Value, which we refer to as an Interest Barrier. The notes may be redeemed early, in whole but not in part, at our option on any of the Interest Payment Dates (other than the first through seventeenth and final Interest Payment Dates). The earliest date on which the notes may be redeemed early is September 30, 2027. Investors should be willing to accept the risk of losing some or all of their principal and the risk that no Contingent Interest Payment may be made with respect to some or all Review Dates. Investors should also be willing to forgo fixed interest and dividend payments, in exchange for the opportunity to receive Contingent Interest Payments. The notes are unsecured and unsubordinated obligations of JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan Financial, the payment on which is fully and unconditionally guaranteed by JPMorgan Chase & Co. Any payment on the notes is subject to the credit risk of JPMorgan Financial, as issuer of the notes, and the credit risk of JPMorgan Chase & Co., as guarantor of the notes. Payments on the notes are not linked to a basket composed of the Indices. Payments on the notes are linked to the performance of each of the Indices individually, as described below. Minimum denominations of $1,000 and integral multiples thereof The notes are expected to price on or about March 27, 2026 and are expected to settle on or about April 1, 2026. CUSIP: 46660RH49 Investing in the notes involves a number of risks. See "Risk Factors" beginning on page S-2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, "Risk Factors" beginning on page PS-11 of the accompanying product supplement and "Selected Risk Considerations" beginning on page PS-5 of this pricing supplement. Neither the Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing supplement or the accompanying product supplement, underlying supplement, prospectus supplement, prospectus and prospectus addendum. Any representation to the contrary is a criminal offense. Price to Public (1) Fees and Commissions (2) Proceeds to Issuer Per note $1,000 $ $ Total $ $ $ (1) See "Supplemental Use of Proceeds" in this pricing supplement for information about the components of the price to public of the notes. (2) J.P. Morgan Securities LLC, which we refer to as JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions it receives from us to other affiliated or unaffiliated dealers. In no event will these selling commissions exceed $7.25 per $1,000 principal amount note. See "Plan of Distribution (Conflicts of Interest)" in the accompanying product supplement. If the notes priced today, the estimated value of the notes would be approximately $974.30 per $1,000 principal amount note. The estimated value of the notes, when the terms of the notes are set, will be provided in the pricing supplement and will not be less than $900.00 per $1,000 principal amount note. See "The Estimated Value of the Notes" in this pricing supplement for additional information. The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank. Pricing supplement to product supplement no. 4-I dated April 13, 2023, underlying supplement no. 1-I dated April 13, 2023, the prospectus and prospectus supplement, each dated April 13, 2023, and the prospectus addendum dated June 3, 2024 Key Terms Issuer: JPMorgan Chase Financial Company LLC, a direct, wholly owned finance subsidiary of JPMorgan Chase & Co. Guarantor: JPMorgan Chase & Co. Indices: The Dow Jones Industrial Average (Bloomberg ticker: INDU), the Nasdaq-100 Technology Sector Index SM (Bloomberg ticker: NDXT) and the

View Full Filing

View this 424B2 filing on SEC EDGAR